Initiation https://www.benzinga.com/views/taxonomy/term/71 en Benzinga's Top Upgrades, Downgrades For May 12, 2020 https://www.benzinga.com/markets/penny-stocks/20/05/16010883/benzingas-top-upgrades-downgrades-for-may-12-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>Guggenheim upgraded the stock for&nbsp;<strong>Amneal Pharmaceuticals Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amrx#NYSE">AMRX</a>) from Sell to Neutral. In the first quarter, Amneal Pharmaceuticals showed an EPS of&nbsp;$0.20, compared to&nbsp;$0.14 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$11.15 and a 52-week-low of&nbsp;$2.27. Amneal Pharmaceuticals&#39;s stock last closed at&nbsp;$4.56 per share.</li> <li>Wedbush upgraded the stock for&nbsp;<strong>CarMax Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmx#NYSE">KMX</a>) from Neutral to Outperform. CarMax earned&nbsp;$1.30 in the fourth quarter, compared to&nbsp;$1.13 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$103.18 and a 52-week-low of&nbsp;$37.59. CarMax&#39;s stock last closed at&nbsp;$76.01 per share.</li> <li>CL King changed the rating for&nbsp;<strong>J&amp;J Snack Foods Corp</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jjsf#NASDAQ">JJSF</a>) from Neutral to Buy. J&amp;J Snack Foods earned&nbsp;$0.38 in the second quarter, compared to&nbsp;$1.08 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$196.84 and a 52-week-low of&nbsp;$105.67. J&amp;J Snack Foods&#39;s stock last closed at&nbsp;$121.55 per share.</li> <li>For&nbsp;<strong>Pinnacle West Capital Corp</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pnw#NYSE">PNW</a>), Guggenheim upgraded the stock from Neutral to Buy. Pinnacle West Capital earned&nbsp;$0.27 in the first quarter, compared to&nbsp;$0.16 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$105.51 and a 52-week-low of&nbsp;$60.05. Pinnacle West Capital&#39;s stock last closed at&nbsp;$73.67 per share.</li> <li>H.C. Wainwright upgraded the stock for&nbsp;<strong>Pulse Biosciences Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) from Neutral to Buy. In the first quarter, Pulse Biosciences showed an EPS of ($0.57), compared to ($0.49) from the year-ago quarter. The stock has a 52-week-high of&nbsp;$17.45 and a 52-week-low of&nbsp;$5.11. Pulse Biosciences&#39;s stock last closed at&nbsp;$11.74 per share.</li> <li>Raymond James changed the rating for&nbsp;<strong>Uniti Group Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/unit#NASDAQ">UNIT</a>) from Outperform to Strong Buy. Uniti Group earned&nbsp;$0.45 in the first quarter. The stock has a 52-week-high of&nbsp;$11.85 and a 52-week-low of&nbsp;$4.86. Uniti Group&#39;s stock last closed at&nbsp;$7.13 per share.</li> <li>Goldman Sachs upgraded the stock for&nbsp;<strong>Axalta Coating Systems Ltd</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) from Neutral to Buy. In the first quarter, Axalta Coating Sys showed an EPS of&nbsp;$0.31, compared to&nbsp;$0.34 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$32.20 and a 52-week-low of&nbsp;$12.92. Axalta Coating Sys&#39;s stock last closed at&nbsp;$19.63 per share.</li> <li>Raymond James changed the rating for&nbsp;<strong>CymaBay Therapeutics Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbay#NASDAQ">CBAY</a>) from Market Perform to Outperform. For the first quarter, CymaBay Therapeutics had an EPS of ($0.19), compared to year-ago quarter EPS of ($0.37). The stock has a 52-week-high of&nbsp;$13.32 and a 52-week-low of&nbsp;$1.21. CymaBay Therapeutics&#39;s stock last closed at&nbsp;$1.84 per share.</li> <li>HSBC upgraded the stock for&nbsp;<strong>Liberty Global PLC</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lbtya#NASDAQ">LBTYA</a>) from Hold to Buy. In the first quarter, Liberty Global showed an EPS of&nbsp;$1.50, compared to ($0.43) from the year-ago quarter. The stock has a 52-week-high of&nbsp;$28.62 and ...</li></ul><p><a href=https://www.benzinga.com/markets/penny-stocks/20/05/16010883/benzingas-top-upgrades-downgrades-for-may-12-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 12, 2020>Full story available on Benzinga.com</a></p> ALB ALDX AMRX ARVN AXTA CBAY CLR CMI CNP CRNC CVX ES EVLO Initiations JJSF KMX LBTYA MMC MRKR ON PCAR Penny Stocks PINC PLSE PNW POR QDEL SWK TCP top upgrades UNIT WMB Upgrades Downgrades Initiation Intraday Update Analyst Ratings JJSF US4660321096 LBTYA US5305551013 PCAR US6937181088 QDEL US74838J1016 ALB US0126531013 CLR US2120151012 CMI US2310211063 CNP US15189T1079 CVX US1667641005 ES US2927562023 KMX US1431301027 MMC US5717481023 PNW US7234841010 POR US7365088472 SWK US8545021011 WMB US9694571004 TCP ON AMRX PINC ALDX CBAY AXTA EVLO PLSE UNIT ARVN MRKR CRNC Penny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Tue, 12 May 2020 13:51:03 +0000 Lisa Levin 16010883 at https://www.benzinga.com Why AbbVie's Stock Is Trading Higher Today https://www.benzinga.com/news/20/05/16003203/why-abbvies-stock-is-trading-higher-today <p><strong>AbbVie</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abbv#NYSE">ABBV</a>) shares are trading higher on Monday.</p> <p>Morgan Stanley analysts reinstated coverage on AbbVie with an Overweight rating and $95 price target, saying they view Humira erosion fears as &quot;overly discounted&quot; and that they see a &quot;positive risk-reward skew&quot; given the company&#39;s dividend yield.</p> <p>AbbVie is a drug company with a strong exposure to immunology and oncology. The company&#39;s top ...</p><p><a href=https://www.benzinga.com/news/20/05/16003203/why-abbvies-stock-is-trading-higher-today alt=Why AbbVie&#039;s Stock Is Trading Higher Today>Full story available on Benzinga.com</a></p> ABBV why it's moving Price Target Initiation Analyst Ratings Movers Trading Ideas ABBV Price Target Initiation Analyst Ratings Movers Trading Ideas Benzinga Mon, 11 May 2020 18:30:48 +0000 Tanzeel Akhtar 16003203 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 11, 2020 https://www.benzinga.com/markets/penny-stocks/20/05/16000601/benzingas-top-upgrades-downgrades-for-may-11-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>For&nbsp;<strong>Americold Realty Trust</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cold#NYSE">COLD</a>), B of A Securities upgraded the stock from Neutral to Buy. In the first quarter, Americold Realty Trust showed an EPS of&nbsp;$0.29, compared to&nbsp;$0.26 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$40.42 and a 52-week-low of&nbsp;$23.30. Americold Realty Trust&#39;s stock last closed at&nbsp;$35.29 per share.</li> <li>RBC Capital changed the rating for&nbsp;<strong>Vale SA</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vale#NYSE">VALE</a>) from Sector Perform to Outperform. Vale earned&nbsp;$0.05 in the first quarter. The stock has a 52-week-high of&nbsp;$14.19 and a 52-week-low of&nbsp;$6.49. Vale&#39;s stock last closed at&nbsp;$8.51 per share.</li> <li>HSBC upgraded the stock for&nbsp;<strong>Carnival Corp</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccl#NYSE">CCL</a>) from Hold to Buy. Carnival earned&nbsp;$0.22 in the first quarter, compared to&nbsp;$0.49 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$54.44 and a 52-week-low of&nbsp;$7.80. Carnival&#39;s stock last closed at&nbsp;$14.19 per share.</li> <li>Evercore ISI Group changed the rating for&nbsp;<strong>UDR Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/udr#NYSE">UDR</a>) from Underperform to In-Line. For the first quarter, UDR had an EPS of&nbsp;$0.54, compared to year-ago quarter EPS of&nbsp;$0.50. The stock has a 52-week-high of&nbsp;$51.25 and a 52-week-low of&nbsp;$29.20. UDR&#39;s stock last closed at&nbsp;$38.37 per share.</li> <li>Bernstein upgraded the stock for&nbsp;<strong>Sabre Corp</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabr#NASDAQ">SABR</a>) from Market Perform to Outperform. For the first quarter, Sabre had an EPS of ($0.29), compared to year-ago quarter EPS of&nbsp;$0.34. The stock has a 52-week-high of&nbsp;$25.44 and a 52-week-low of&nbsp;$3.30. Sabre&#39;s stock last closed at&nbsp;$6.72 per share.</li> </ul> <p>&nbsp;</p> <h3 id="downgrades">Downgrades</h3> <ul> <li>For&nbsp;<strong>CF Industries Holdings Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cf#NYSE">CF</a>), B of A Securities downgraded the stock from Buy to Underperform. CF Industries Holdings earned&nbsp;$0.31 in the first quarter, compared to&nbsp;$0.40 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$55.15 and a 52-week-low of&nbsp;$19.73. CF Industries Holdings&#39;s stock last closed ...</li></ul><p><a href=https://www.benzinga.com/markets/penny-stocks/20/05/16000601/benzingas-top-upgrades-downgrades-for-may-11-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 11, 2020>Full story available on Benzinga.com</a></p> BAND CAG CARG CCL CF COLD CTVA FRPT GTT ICD IMUX Initiations MESA MNST MOS Penny Stocks RDFN SABR top upgrades UDR UFS VALE Upgrades Downgrades Initiation Intraday Update Analyst Ratings FRPT MESA CAG US2058871029 CCL PA1436583006 CF US1252691001 MOS US61945C1036 UDR US9026531049 UFS US2575592033 VALE US91912E1055 MNST GTT SABR ICD RDFN CARG BAND COLD IMUX CTVA Penny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Mon, 11 May 2020 14:01:48 +0000 Lisa Levin 16000601 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 8, 2020 https://www.benzinga.com/analyst-ratings/upgrades/20/05/15992308/benzingas-top-upgrades-downgrades-for-may-8-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>For&nbsp;<strong>Uber Technologies Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>), CFRA upgraded the stock from Hold to Buy. In the first quarter, Uber Technologies showed an EPS of ($0.64), compared to ($2.26) from the year-ago quarter. The stock has a 52-week-high of&nbsp;$47.08 and a 52-week-low of&nbsp;$13.71. Uber Technologies&#39;s stock last closed at&nbsp;$30.89 per share.</li> <li>JP Morgan upgraded <strong>Hain Celestial Group, Inc. </strong>(NASDAQ:<a class="ticker" href="https://pro.benzinga.com/stock/HAIN#NASDAQ"> HAIN</a>) from Underweight to Neutral.&nbsp;Hain Celestial shares closed at $28.77 on Thursday.</li> <li>CFRA changed the rating for&nbsp;<strong>Wynn Resorts Ltd</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wynn#NASDAQ">WYNN</a>) from Strong Sell to Hold. Wynn Resorts earned ($3.54) in the first quarter, compared to&nbsp;$1.61 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$153.41 and a 52-week-low of&nbsp;$35.84. Wynn Resorts&#39;s stock last closed at&nbsp;$79.60 per share.</li> <li>Craig-Hallum upgraded <strong>Carrols Restaurant Group, Inc. </strong>(NASDAQ:<a class="ticker" href="https://pro.benzinga.com/stock/TAST#NASDAQ"> ...</a></li></ul><p><a href=https://www.benzinga.com/analyst-ratings/upgrades/20/05/15992308/benzingas-top-upgrades-downgrades-for-may-8-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 8, 2020>Full story available on Benzinga.com</a></p> APA CBRE Initiations SAGE top upgrades UBER WYNN Upgrades Downgrades Initiation Intraday Update Analyst Ratings WYNN US9831341071 APA US0374111054 CBRE SAGE UBER Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Fri, 08 May 2020 19:03:27 +0000 Lisa Levin 15992308 at https://www.benzinga.com Why Dynatrace's Stock Is Trading Higher Today https://www.benzinga.com/news/20/05/15979854/why-dynatraces-stock-is-trading-higher-today <p><strong>Dynatrace</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dt#NYSE">DT</a>)shares are trading higher on Thursday after Needham initiated coverage on the stock with a Buy rating and a $36 price target.</p> <p>Dynatrace offers software intelligence platform for the enterprise cloud. The intelligence platform is designed to address the growing complexity faced by technology and digital business teams.</p> <p>The platform utilizes artificial intelligence at its core ...</p><p><a href=https://www.benzinga.com/news/20/05/15979854/why-dynatraces-stock-is-trading-higher-today alt=Why Dynatrace&#039;s Stock Is Trading Higher Today>Full story available on Benzinga.com</a></p> DT News why it's moving Price Target Initiation Analyst Ratings DT News Price Target Initiation Analyst Ratings Benzinga Thu, 07 May 2020 15:51:47 +0000 Tanzeel Akhtar 15979854 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 7, 2020 https://www.benzinga.com/markets/penny-stocks/20/05/15978447/benzingas-top-upgrades-downgrades-for-may-7-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>B of A Securities upgraded the stock for&nbsp;<strong>BWX Technologies Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bwxt#NYSE">BWXT</a>) from Underperform to Neutral. For the first quarter, BWX Technologies had an EPS of&nbsp;$0.79, compared to year-ago quarter EPS of&nbsp;$0.51. The stock has a 52-week-high of&nbsp;$70.57 and a 52-week-low of&nbsp;$40.40. BWX Technologies&#39;s stock last closed at&nbsp;$55.75 per share.</li> <li>Deutsche Bank changed the rating for&nbsp;<strong>General Motors Co</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gm#NYSE">GM</a>) from Hold to Buy. General Motors earned&nbsp;$0.62 in the first quarter, compared to&nbsp;$1.41 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$41.90 and a 52-week-low of&nbsp;$14.32. General Motors&#39;s stock last closed at&nbsp;$21.89 per share.</li> <li>Raymond James upgraded the stock for&nbsp;<strong>National Fuel Gas Co</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nfg#NYSE">NFG</a>) from Market Perform to Outperform. For the second quarter, National Fuel Gas had an EPS of&nbsp;$0.97, compared to year-ago quarter EPS of&nbsp;$1.07. The stock has a 52-week-high of&nbsp;$58.37 and a 52-week-low of&nbsp;$31.58. National Fuel Gas&#39;s stock last closed at&nbsp;$38.71 per share.</li> <li>HSBC upgraded the stock for&nbsp;<strong>Tapestry Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpr#NYSE">TPR</a>) from Hold to Buy. For the third quarter, Tapestry had an EPS of ($0.27), compared to year-ago quarter EPS of&nbsp;$0.42. The stock has a 52-week-high of&nbsp;$36.06 and a 52-week-low of&nbsp;$10.18. Tapestry&#39;s stock last closed at&nbsp;$14.07 per share.</li> <li>Craig-Hallum changed the rating for&nbsp;<strong>nLight Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lasr#NASDAQ">LASR</a>) from Hold to Buy. For the first quarter, nLight had an EPS of ($0.08), compared to year-ago quarter EPS of&nbsp;$0.02. The stock has a 52-week-high of&nbsp;$26.06 and a 52-week-low of&nbsp;$9.04. nLight&#39;s stock last closed at&nbsp;$17.89 per share.</li> <li>For&nbsp;<strong>National Fuel Gas Co</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nfg#NYSE">NFG</a>), ScotiaBank upgraded ...</li></ul><p><a href=https://www.benzinga.com/markets/penny-stocks/20/05/15978447/benzingas-top-upgrades-downgrades-for-may-7-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 7, 2020>Full story available on Benzinga.com</a></p> ASH AXGN BWXT CGEN CMP DT GM Initiations Integrated Telecommunication Services LASR LYFT NFG OXY Penny Stocks SEDG SHOP SPG Telecommunication Services top upgrades TPR USIO Upgrades Downgrades Initiation Intraday Update Analyst Ratings CGEN IL0010852080 ASH US0442091049 CMP US20451N1019 DT GM US37045V1008 NFG US6361801011 OXY US6745991058 SPG US8288061091 AXGN SEDG SHOP BWXT LYFT TPR LASR USIO Penny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Thu, 07 May 2020 13:54:27 +0000 Lisa Levin 15978447 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 6, 2020 https://www.benzinga.com/analyst-ratings/upgrades/20/05/15970170/benzingas-top-upgrades-downgrades-for-may-6-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>CFRA upgraded the stock for&nbsp;<strong>New York Times Co</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyt#NYSE">NYT</a>) from Hold to Buy. New York Times earned&nbsp;$0.17 in the first quarter, compared to&nbsp;$0.20 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$40.22 and a 52-week-low of&nbsp;$26.13. New York Times&#39;s stock last closed at&nbsp;$33.40 per share.</li> <li>Deutsche Bank upgraded <strong>Illinois Tool Works Inc</strong> (NYSE: <a class="ticker" href="https://pro.benzinga.com/stock/ITW#NYSE">ITW</a>) from Sell to Hold. Illinois Tool Works sharse closed at $159.69 on Tuesday.</li> <li>JP Morgan upgraded <strong>PPG Industries, Inc.</strong> (NYSE: <a class="ticker" href="https://pro.benzinga.com/stock/PPG#NYSE">PPG</a>) from Neutral to Overweight. PPG shares closed at $88.27 on Tuesday.</li> <li>Raymond James upgraded <strong>American Eagle Outfitters, Inc.</strong> (NYSE: <a class="ticker" href="https://pro.benzinga.com/stock/AEO#NYSE">AEO</a>) from Market Perform to Outperform. American Eagle shares closed at $7.24 on Tuesday.</li> </ul> <p>&nbsp;</p> <h3 id="downgrades">Downgrades</h3> <ul> <li>For&nbsp;<strong>Discovery Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/disca#NASDAQ">DISCA</a>), CFRA downgraded the stock from Buy to Hold. For the first quarter, Discovery ...</li></ul><p><a href=https://www.benzinga.com/analyst-ratings/upgrades/20/05/15970170/benzingas-top-upgrades-downgrades-for-may-6-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 6, 2020>Full story available on Benzinga.com</a></p> AGS DISCA EQR IGT Initiations NYT top upgrades VMC Upgrades Downgrades Initiation Intraday Update Analyst Ratings DISCA US25470F1049 EQR US29476L1070 IGT US4599021023 NYT US6501111073 VMC US9291601097 AGS Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Wed, 06 May 2020 18:08:51 +0000 Lisa Levin 15970170 at https://www.benzinga.com Analyst Likes DraftKings As Public Embraces Legal Sports Betting https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15958321/analyst-likes-draftkings-as-public-embraces-legal-sports-betting <p>The case for investing in providers of legalized gambling like DraftKings in the U.S. is based in part on encouraging trends elsewhere in the world, according to Canaccord Genuity.</p> <p>DraftKings and SBTech were acquired by <strong>Diamond Eagle Acquisition Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>), which merged into a new DraftKings entity.</p> <h3>The DraftKings Analyst</h3> <p><a href="https://www.tipranks.com/analysts/michael-graham">Michael Graham</a> initiated coverage on the stock with a Buy rating and $25 price target.</p> <h3>The DraftKings Thesis</h3> <p>Graham said investors should look towards the United Kingdom to better understand the growth potential DraftKing faces in the U.S. as the public starts to &quot;embrace&quot; legalized sports betting. Most notably, online sports betting is around 2.5 times larger than in-person sports betting ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15958321/analyst-likes-draftkings-as-public-embraces-legal-sports-betting alt=Analyst Likes DraftKings As Public Embraces Legal Sports Betting>Full story available on Benzinga.com</a></p> Analyst Color DKNG DraftKings Michael Graham sports betting Price Target Initiation Sports Analyst Ratings General DKNG Analyst Color Price Target Initiation Sports Analyst Ratings General Benzinga Tue, 05 May 2020 19:49:48 +0000 Jayson Derrick 15958321 at https://www.benzinga.com Why Immunomedics Is Trading Higher Today https://www.benzinga.com/news/20/05/15956898/why-immunomedics-is-trading-higher-today <p><strong>Immunomedics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/immu#NASDAQ">IMMU</a>) shares are trading higher on Tuesday, after Barclays initiated coverage on the company&#39;s stock with an Overweight rating and $40 price target.</p> <p>Immunomedics&nbsp;is a clinical-stage biopharmaceutical company, based in the U.S. The company develops monoclonal antibody-based products for the targeted treatment of cancer and ...</p><p><a href=https://www.benzinga.com/news/20/05/15956898/why-immunomedics-is-trading-higher-today alt=Why Immunomedics Is Trading Higher Today>Full story available on Benzinga.com</a></p> IMMU News why it's moving Price Target Initiation Analyst Ratings IMMU US4529071080 News Price Target Initiation Analyst Ratings Benzinga Tue, 05 May 2020 16:00:31 +0000 Tanzeel Akhtar 15956898 at https://www.benzinga.com Why Viking Therapeutics Is Trading Higher Today https://www.benzinga.com/news/20/05/15956779/why-viking-therapeutics-is-trading-higher-today <p><strong>Viking Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) shares are trading higher on Tuesday, after Chardan initiated coverage on the company&#39;s stock with a Buy rating and $15 price target.</p> <p>Viking Therapeutics is a health care service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company&#39;s clinical program pipeline consists of ...</p><p><a href=https://www.benzinga.com/news/20/05/15956779/why-viking-therapeutics-is-trading-higher-today alt=Why Viking Therapeutics Is Trading Higher Today>Full story available on Benzinga.com</a></p> News VKTX why it's moving Price Target Initiation Analyst Ratings Movers Trading Ideas VKTX News Price Target Initiation Analyst Ratings Movers Trading Ideas Benzinga Tue, 05 May 2020 15:59:16 +0000 Tanzeel Akhtar 15956779 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 5, 2020 https://www.benzinga.com/analyst-ratings/upgrades/20/05/15955292/benzingas-top-upgrades-downgrades-for-may-5-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>SunTrust Robinson Humphrey upgraded the stock for&nbsp;<strong>Adverum Biotechnologies Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/advm#NASDAQ">ADVM</a>) from Hold to Buy. Adverum Biotechnologies earned ($0.29) in the fourth quarter, compared to ($0.25) in the year-ago quarter. The stock has a 52-week-high of&nbsp;$16.81 and a 52-week-low of&nbsp;$4.96. Adverum Biotechnologies&#39;s stock last closed at&nbsp;$13.73 per share.</li> <li>BMO Capital upgraded the stock for&nbsp;<strong>L Brands Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lb#NYSE">LB</a>) from Market Perform to Outperform. For the fourth quarter, L Brands had an EPS of&nbsp;$1.88, compared to year-ago quarter EPS of&nbsp;$2.14. The stock has a 52-week-high of&nbsp;$28.02 and a 52-week-low of&nbsp;$8.00. L Brands&#39;s stock last closed at&nbsp;$12.05 per share.</li> <li>For&nbsp;<strong>Skyworks Solutions Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swks#NASDAQ">SWKS</a>), Charter Equity upgraded the stock from Market Perform to Market Outperform. In the second quarter, Skyworks Solutions showed an EPS of&nbsp;$1.34, compared to&nbsp;$1.47 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$128.48 and a 52-week-low of&nbsp;$66.29. Skyworks Solutions&#39;s stock last closed at&nbsp;$99.61 per share.</li> <li>For&nbsp;<strong>BioCryst Pharmaceuticals Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>), Barclays upgraded the stock from Equal-Weight to Overweight. For the fourth quarter, BioCryst Pharmaceuticals had an EPS of ($0.02), compared to year-ago quarter EPS of ($0.25). The stock has a 52-week-high of&nbsp;$8.15 and a 52-week-low of&nbsp;$1.38. BioCryst Pharmaceuticals&#39;s stock last closed at&nbsp;$3.93 per share.</li> <li>For&nbsp;<strong>Chegg Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chgg#NYSE">CHGG</a>), Raymond James upgraded the stock from Market Perform to Outperform. For the first quarter, Chegg had an EPS of&nbsp;$0.22, compared to year-ago quarter EPS of&nbsp;$0.15. The stock has a 52-week-high of&nbsp;$48.22 and a 52-week-low of&nbsp;$25.89. Chegg&#39;s stock last closed at&nbsp;$43.85 per share.</li> <li>Atlantic Equities upgraded the stock for&nbsp;<strong>First Republic Bank</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frc#NYSE">FRC</a>) from Underweight to Neutral. First Republic Bank earned&nbsp;$1.20 in the first quarter, compared to&nbsp;$1.26 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$122.34 and a 52-week-low of&nbsp;$70.06. First Republic Bank&#39;s stock last closed at&nbsp;$98.93 per share.</li> <li>Stifel changed the rating for&nbsp;<strong>Cutera Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cutr#NASDAQ">CUTR</a>) from Hold to Buy. Cutera earned&nbsp;$0.14 in the fourth quarter, compared to ($0.11) in the year-ago quarter. The stock has a 52-week-high of&nbsp;$39.15 and a 52-week-low of&nbsp;$9.07. Cutera&#39;s stock last closed at&nbsp;$12.90 per share.</li> </ul> <p>&nbsp;</p> <h3 id="downgrades">Downgrades</h3> <ul> <li>For&nbsp;<strong>Stemline Therapeutics Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stml#NASDAQ">STML</a>), Ladenburg Thalmann downgraded the stock from Buy to Neutral. For the fourth quarter, Stemline Therapeutics had an EPS of ($0.38), compared to year-ago quarter EPS of ($0.92). The stock has a 52-week-high of&nbsp;$18.22 and a 52-week-low of&nbsp;$3.21. Stemline Therapeutics&#39;s stock last closed at&nbsp;$12.11 per share.</li> <li>B of A Securities changed the rating for&nbsp;<strong>Tyson Foods Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsn#NYSE">TSN</a>) from Buy to Neutral. For the second ...</li></ul><p><a href=https://www.benzinga.com/analyst-ratings/upgrades/20/05/15955292/benzingas-top-upgrades-downgrades-for-may-5-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 5, 2020>Full story available on Benzinga.com</a></p> ADVM BCRX BLDR BPMC CARS CHGG CRM CUTR CYTK DKNG FIVN FRC IMMU Initiations KURA LB MDGL OKE OMI REPL STML SWKS SWTX top upgrades TSN VKTX VRNS WDAY WFC Upgrades Downgrades Initiation Intraday Update Analyst Ratings BCRX US09058V1035 BLDR US12008R1077 CUTR US2321091082 CYTK US23282W1009 IMMU US4529071080 SWKS US83088M1027 CRM US79466L3024 OKE US6826801036 OMI US6907321029 TSN US9024941034 WFC US9497461015 FRC US33616C1009 SWTX CARS WDAY REPL STML CHGG LB US5024701071 VRNS FIVN VKTX BPMC KURA ADVM MDGL DKNG Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Tue, 05 May 2020 13:35:04 +0000 Lisa Levin 15955292 at https://www.benzinga.com 3 Keros Analysts On Why Biopharma Is A Compelling Investment Opportunity https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15945571/3-keros-analysts-on-why-biopharma-is-a-compelling-investment-opportunity <p><strong>Keros Therapeutics Inc </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kros#NASDAQ">KROS</a>), a clinical-stage biopharma focused on the development of treatments for rare hematologic and musculoskeletal disorders, <a href="https://www.benzinga.com/general/biotech/20/04/15765107/the-daily-biotech-pulse-genmark-pre-announces-q1-outperformance-sage-to-eliminate-53-of-workforce">went public in April.&nbsp;</a></p> <p>With the IPO quiet period expiring, analysts are starting coverage of the stock &mdash; and adopting a bullish stance.</p> <h3>The Keros Analysts</h3> <p>SVB Leerink analyst <a href="https://www.tipranks.com/analysts/thomas-smith"> Thomas Smith </a> initiated coverage of the <a href=" https://www.benzinga.com/stock/kros/ratings"> stock </a> with an Outperform rating and $42 price target.</p> <p>Jefferies analyst <a href="https://www.tipranks.com/analysts/eun-yang"> Eun Yang </a> initiated Keros at Buy with a $37 price target.&nbsp;</p> <p>Piper Sandler analyst <a href="https://www.tipranks.com/analysts/danielle-brill"> Danielle Brill </a> initiated the stock at Overweight with a&nbsp;$35 price target.</p> <h3>Lead Asset Has Blockbuster Potential, SVB Leerink Says</h3> <p>Keros&#39; lead asset KER-050 is a Phase 2-ready ActRIIA-Fc fusion protein meant to promote red blood cell and platelet differentiation and maturation in both early and late-stage hematopoiesis, SVB Leerink analyst Smith said in a Monday initiation note.&nbsp;</p> <p>The analyst sees the success of other TGF-beta ligand traps such as <strong>Acceleron Pharma Inc </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xlrn#NASDAQ">XLRN</a>) and <strong>Bristol-Myers Squibb Co </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmy#NYSE">BMY</a>)&#39;s anemia correction ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15945571/3-keros-analysts-on-why-biopharma-is-a-compelling-investment-opportunity alt=3 Keros Analysts On Why Biopharma Is A Compelling Investment Opportunity>Full story available on Benzinga.com</a></p> Analyst Color Biotech BMY Danielle Brill Eun Yang Jefferies KROS Piper Sandler SVB Leerink Thomas Smith XLRN Price Target Initiation Analyst Ratings Trading Ideas BMY US1101221083 XLRN KROS Analyst Color Biotech Price Target Initiation Analyst Ratings Trading Ideas Benzinga Mon, 04 May 2020 18:41:48 +0000 Shanthi Rexaline 15945571 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 4, 2020 https://www.benzinga.com/analyst-ratings/upgrades/20/05/15947775/benzingas-top-upgrades-downgrades-for-may-4-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>CFRA upgraded the stock for&nbsp;<strong>Molina Healthcare Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/moh#NYSE">MOH</a>) from Hold to Buy. In the first quarter, Molina Healthcare showed an EPS of&nbsp;$3.02, compared to&nbsp;$3.04 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$175.00 and a 52-week-low of&nbsp;$102.85. Molina Healthcare&#39;s stock last closed at&nbsp;$172.90 per share.</li> <li>For&nbsp;<strong>Idacorp Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ida#NYSE">IDA</a>), Sidoti &amp; Co. upgraded the stock from Neutral to Buy. Idacorp earned&nbsp;$0.74 in the first quarter, compared to&nbsp;$0.84 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$114.01 and a 52-week-low of&nbsp;$69.05. Idacorp&#39;s stock last closed at&nbsp;$88.33 per share.</li> <li>UBS changed the rating for&nbsp;<strong>Choice Hotels International Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chh#NYSE">CHH</a>) from Neutral to Buy. For the fourth quarter, Choice Hotels Intl had an EPS of&nbsp;$0.92, compared to year-ago quarter EPS of&nbsp;$0.88. The stock has a 52-week-high of&nbsp;$109.26 and a 52-week-low of&nbsp;$46.25. Choice Hotels Intl&#39;s stock last closed at&nbsp;$71.29 per share.</li> </ul> <p>&nbsp;</p> <h3 id="downgrades">Downgrades</h3> <ul> <li>Cantor Fitzgerald changed the rating for&nbsp;<strong>Stemline Therapeutics Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stml#NASDAQ">STML</a>) from Overweight to Neutral. In the fourth quarter, Stemline Therapeutics showed an EPS of ($0.38), compared to ($0.92) from the year-ago quarter. The stock ...</li></ul><p><a href=https://www.benzinga.com/analyst-ratings/upgrades/20/05/15947775/benzingas-top-upgrades-downgrades-for-may-4-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 4, 2020>Full story available on Benzinga.com</a></p> BDTX CHH CLR DKNG IDA Information Technology Initiations JD MOH MXL OXY REXR Semiconductors SSTI STML top upgrades Upgrades Downgrades Initiation Intraday Update Analyst Ratings SSTI CHH US1699051066 CLR US2120151012 IDA US4511071064 MOH US60855R1005 OXY US6745991058 MXL US57776J1007 STML REXR JD BDTX DKNG Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Mon, 04 May 2020 18:36:19 +0000 Lisa Levin 15947775 at https://www.benzinga.com Qualcomm Is A Victim Of Its Own Success, Says Bearish Wells Fargo https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15944656/qualcomm-is-a-victim-of-its-own-success-says-bearish-wells-fargo <p><strong>Qualcomm, Inc&rsquo;s </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qcom#NASDAQ">QCOM</a>) success limits its ability to gain the market share needed to grow in the smartphone space, which is mature and stagnant, according to Wells Fargo.</p> <h3>The Qualcomm Analyst</h3> <p><a href="https://www.tipranks.com/analysts/gary-mobley">Gary Mobley</a> initiated coverage of Qualcomm with an Underweight rating and $70 price target.&nbsp;</p> <h3>The Qualcomm Thesis</h3> <p>Given Qualcomm&rsquo;s dominance of the smartphone market, there is an industry-wide reluctance to rely too heavily on the company&rsquo;s MSM processors and related radio frequency front end&nbsp;solutions, Mobley said in a Monday initiation note. (See his track record <a href="http://www.tipranks.com/analysts/gary-mobley">here</a>.)</p> <p>This, coupled with the need for anti-competitive ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15944656/qualcomm-is-a-victim-of-its-own-success-says-bearish-wells-fargo alt=Qualcomm Is A Victim Of Its Own Success, Says Bearish Wells Fargo>Full story available on Benzinga.com</a></p> Analyst Color Gary Mobley QCOM Wells Fargo Price Target Initiation Analyst Ratings QCOM US7475251036 Analyst Color Price Target Initiation Analyst Ratings Benzinga Mon, 04 May 2020 14:30:08 +0000 Priya Nigam 15944656 at https://www.benzinga.com Benzinga's Top Upgrades, Downgrades For May 1, 2020 https://www.benzinga.com/analyst-ratings/upgrades/20/05/15933430/benzingas-top-upgrades-downgrades-for-may-1-2020 <h3 id="upgrades">Upgrades</h3> <ul> <li>Piper Sandler changed the rating for&nbsp;<strong>Lakeland Bancorp Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lbai#NASDAQ">LBAI</a>) from Neutral to Overweight. For the first quarter, Lakeland Bancorp had an EPS of&nbsp;$0.24, compared to year-ago quarter EPS of&nbsp;$0.35. The stock has a 52-week-high of&nbsp;$17.63 and a 52-week-low of&nbsp;$8.31. Lakeland Bancorp&#39;s stock last closed at&nbsp;$11.19 per share.</li> <li>KeyBanc upgraded the stock for&nbsp;<strong>Wolverine World Wide Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/www#NYSE">WWW</a>) from Sector Weight to Overweight. In the first quarter, Wolverine World Wide showed an EPS of&nbsp;$0.28, compared to&nbsp;$0.49 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$37.58 and a 52-week-low of&nbsp;$12.19. Wolverine World Wide&#39;s stock last closed at&nbsp;$20.85 per share.</li> <li>Janney Capital changed the rating for&nbsp;<strong>California Water Service Group</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cwt#NYSE">CWT</a>) from Neutral to Buy. California Water Service earned ($0.42) in the first quarter, compared to ($0.16) in the year-ago quarter. The stock has a 52-week-high of&nbsp;$57.48 and a 52-week-low of&nbsp;$39.74. California Water Service&#39;s stock last closed at&nbsp;$45.15 per share.</li> <li>For&nbsp;<strong>Seattle Genetics Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgen#NASDAQ">SGEN</a>), Guggenheim upgraded the stock from Neutral to Buy. For the first quarter, Seattle Genetics had an EPS of ($0.98), compared to year-ago quarter EPS of ($0.08). The stock has a 52-week-high of&nbsp;$150.00 and a 52-week-low of&nbsp;$62.90. Seattle Genetics&#39;s stock last closed at&nbsp;$137.23 per share.</li> </ul> <p>&nbsp;</p> <h3 id="downgrades">Downgrades</h3> <ul> <li>BTIG downgraded the stock for&nbsp;<strong>On Deck Capital Inc</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ondk#NYSE">ONDK</a>) from Buy to Neutral. In the first quarter, On Deck Capital showed an EPS of ($0.92), compared to&nbsp;$0.10 from the year-ago quarter. The stock has a 52-week-high of&nbsp;$5.69 and a 52-week-low of&nbsp;$0.54. On Deck Capital&#39;s stock last closed at&nbsp;$1.20 per share.</li> <li>For&nbsp;<strong>Autodesk Inc</strong>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adsk#NASDAQ">ADSK</a>), Bernstein downgraded the stock from Market Perform to Underperform. Autodesk earned&nbsp;$0.92 in the fourth quarter, compared to&nbsp;$0.46 in the year-ago quarter. The stock has a 52-week-high of&nbsp;$211.58 and a 52-week-low of&nbsp;$125.38. Autodesk&#39;s stock last closed at&nbsp;$187.13 per share.</li> <li>Credit Suisse changed the rating for&nbsp;<strong>Cabot Oil &amp; Gas Corp</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cog#NYSE">COG</a>) from Outperform to Neutral. In the first quarter, Cabot ...</li></ul><p><a href=https://www.benzinga.com/analyst-ratings/upgrades/20/05/15933430/benzingas-top-upgrades-downgrades-for-may-1-2020 alt=Benzinga&#039;s Top Upgrades, Downgrades For May 1, 2020>Full story available on Benzinga.com</a></p> ADSK ATSG AXLA BYND CERN COG CWT DOW EME FGEN GILD HUBG HURN Initiations LBAI ONDK SGEN top upgrades TXT VKTX WLTW WWW YMAB Upgrades Downgrades Initiation Intraday Update Analyst Ratings ADSK US0527691069 ATSG US00922R1059 CERN US1567821046 GILD US3755581036 HUBG US4433201062 HURN US4474621020 LBAI US5116371007 SGEN US8125781026 COG US1270971039 CWT US1307881029 DOW US2605431038 EME US29084Q1004 TXT US8832031012 WWW US9780971035 VKTX ONDK FGEN WLTW YMAB BYND AXLA Upgrades Downgrades Initiation Intraday Update Analyst Ratings Benzinga Fri, 01 May 2020 13:40:08 +0000 Lisa Levin 15933430 at https://www.benzinga.com